These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21671467)

  • 1. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.
    Huang XH; Chen JS; Wang Q; Chen XL; Wen L; Chen LZ; Bi J; Zhang LJ; Su Q; Zeng WT
    J Pathol; 2011 Nov; 225(3):463-72. PubMed ID: 21671467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
    Zhao X; Chen GQ; Cao GM
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma.
    Li Q; Ding C; Chen C; Zhang Z; Xiao H; Xie F; Lei L; Chen Y; Mao B; Jiang M; Li J; Wang D; Wang G
    J Gastroenterol Hepatol; 2014 Apr; 29(4):835-42. PubMed ID: 24219032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
    Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
    Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
    Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z
    PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
    Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z
    Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.
    Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD
    Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
    Tang SJ; Yang JB
    Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-338-3p inhibits colorectal carcinoma cell invasion and migration by targeting smoothened.
    Xue Q; Sun K; Deng HJ; Lei ST; Dong JQ; Li GX
    Jpn J Clin Oncol; 2014 Jan; 44(1):13-21. PubMed ID: 24277750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
    Jiang G; Cui Y; Yu X; Wu Z; Ding G; Cao L
    Oncotarget; 2015 Apr; 6(11):9457-66. PubMed ID: 25888635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
    Cao L; Xie B; Yang X; Liang H; Jiang X; Zhang D; Xue P; Chen D; Shao Z
    PLoS One; 2015; 10(7):e0133074. PubMed ID: 26177288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of long non‑coding RNA NEAT1 inhibits hepatocellular carcinoma progression by downregulating SMO by sponging microRNA‑503.
    Sun C; Xiao T; Xiao Y; Li Y
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33398379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
    Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
    Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
    Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
    PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA MALAT1 Regulates ZEB1 Expression by Sponging miR-143-3p and Promotes Hepatocellular Carcinoma Progression.
    Chen L; Yao H; Wang K; Liu X
    J Cell Biochem; 2017 Dec; 118(12):4836-4843. PubMed ID: 28543721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
    Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
    Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
    Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.